An impressive list of expertise
Over the years, we have developed expertise over essential processes to serve the global consumers with highly innovative and effective products. This enables us to deliver exceptional quality and reliability as an innovator and manufacturer.
Generic Drug Development and Contract Research Services
We deliver high-quality and safe generic drugs to 50+ countries across five continents, driven by the rapid generic drug development and reliable contract research services.
Well-defined process of R&D to Commercial Manufacturing
Cutting-edge research and development, systematic scaling up, contract manufacturing to optimize overall productivity, thorough clinical trials for additional safety evaluation, and solid commercial manufacturing, all in a well-defined step-by-step process.
Analytical method development and validation
Analytical method development and validation helps in getting accurate results and critical assessment of product-specific acceptance criteria.
ANDA Filing
We identify product potential, based on which we develop innovative process solutions. We then take care of the product approvals, finally ending with ANDA filing with the FDA.
IP Formulations and Process Technology
We have developed cost-effective yet highly efficient ways to develop IP oriented formulations. We also make the development of process technologies economical.
Experienced Regulatory Team &
Formulation Development
Our experienced regulatory teams conduct regular quality checks throughout the developmental process to ensure that our complicated generics are effective and safe. Robust API manufacturers back our Formulation Development, making sure our supply chain is reliable and unhindered in the long run.
Novel Drug Delivery Systems, Para IV/ NCE-1 & 505 B2 Development
We have efficient development capability to produce Novel Drug Delivery Systems along with Para IV, NCE-1 and 505 B2.
Manufacturing expertise at our high-tech plants
Atlanta Plant
We manufacture oral solids in the form of tablets and capsules at our state-of-the-art plant in Atlanta, USA.
UNIT I : ORAL SOLIDS
| Dosage Forms | Per Month |
|---|---|
| Tablets | 80 million |
| Capsules | 70 million |
Ahmedabad Plant
Our manufacturing plant at Ahmedabad, India is highly modern and advanced, with a massive production capability. We produce Small Vial Parenterals, Oral Solids & Liquids, Beta Lactum, and Cephalosporins SVP in millions every month, managed by an expert team.
UNIT II : SMALL VOLUME PARENTERALS
| Dosage Forms | Per Month |
|---|---|
| Ampoules | 2 million |
| Liquid Vials | 2 million |
| Dry Powder Vials | 1.25 million |
| Lyophilized Vials | 0.2 million |
UNIT III : ORAL SOLIDS & LIQUIDS
| Dosage Forms | Per Month |
|---|---|
| Tablets | 62.5 million |
| Capsules | 12.5 million |
| Dry Powder | 0.50 million |
| Oral Liquid | 0.625 million |
UNIT IV : BETA LACTUM, ORAL SOLIDS & LIQUIDS
| Dosage Forms | Per Month |
|---|---|
| Tablets | 5 million |
| Capsules | 12.5 million |
| Dry Powder | 5 million |
UNIT V: CEPHALOSPORINS SVP
| Dosage Forms | Per Month |
|---|---|
| Ampoules | 2 million |
| Liquid Vials | 2 million |
